bluebird bio · 2 days ago
Senior Analyst II, Quality Control
Wonder how qualified you are to the job?
Maximize your interview chances
BiotechnologyGenetics
H1B Sponsorship
Insider Connection @bluebird bio
Responsibilities
Designing and overseeing QC laboratory studies for validation and remediation of QC methods.
Authoring and reviewing method lifecycle documents like protocols, reports, and SOPs.
Analyzing data using statistical software and/or Excel.
Owning and supporting cGMP routine testing and quality system records.
Participating in method monitoring of bioassay, molecular, and cell-based methods.
Tracking project status and communicating with cross-functional teams.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s or Master’s degree in Biology, Biochemistry, or related scientific discipline.
A minimum of four (4) years of related experience in a QC GMP environment with late-stage clinical (Phase II, III) or commercial setting; commercial experience a plus.
Experience with development, qualification, and validation of QC test methods (i.e. cell-based assay, potency assay, and/or cell culture experience is desirable).
Experience with owning quality system records required for deviations, laboratory investigations, CAPAs and out-of-specification (OOS) results
Good understanding of or proficiency with statistical software packages, such as JMP or Prism
Company
bluebird bio
Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.
H1B Sponsorship
bluebird bio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Trends of Total Sponsorships
2023 (14)
2022 (15)
2021 (48)
2020 (42)
Funding
Current Stage
Public CompanyTotal Funding
$3.44BKey Investors
Hercules CapitalCalifornia Institute for Regenerative MedicineARCH Venture Partners
2024-03-18Post Ipo Debt· $75M
2023-12-19Post Ipo Equity· $125M
2023-01-18Post Ipo Equity· $120M
Leadership Team
Recent News
2024-05-29
2024-05-23
The Motley Fool
2024-05-23
Company data provided by crunchbase